Galcanezumab for Vestibular Migraine
Clinical trial NCT04417361 · COMPLETED
Trial details
- NCT number
- NCT04417361
- Sponsor
- University of California, San Francisco
- Status
- COMPLETED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2020-09-18
- Primary completion
- 2023-09-29
- Enrollment
- 40
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.